• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可切除食管癌患者诊断与手术之间的延迟会影响生存吗?一项基于西米德兰兹郡癌症登记数据的研究。

Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data.

作者信息

Kötz B S, Croft S, Ferry D R

机构信息

Division of Cancer Studies, University of Birmingham, Birmingham B15 2TT, and The Royal Wolverhampton Hospital NHS Trust, UK.

出版信息

Br J Cancer. 2006 Oct 9;95(7):835-40. doi: 10.1038/sj.bjc.6603333. Epub 2006 Sep 12.

DOI:10.1038/sj.bjc.6603333
PMID:16969353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360528/
Abstract

This retrospective study investigates if delays between the diagnosis of cancer of the oesophagus and surgical resection influence long-term survival. Data held by the West Midlands Cancer Intelligence Unit on 800 patients who underwent oesophagectomy for a diagnosis of cancer of the oesophagus or oesophagogastric junction between 1995 and 2000 were reviewed. Six hundred and thirty-two patients treated with curative intention and who had not received neo-adjuvant treatment in the form of radio- or chemotherapy were included in the analysis. The time interval between histological diagnosis and surgical resection was stratified into four groups: less than 3, 3-6, 6-9 and more than 9 weeks. The Cox proportional hazard model was used to test for the independent effect of delays. The results showed no difference in long-term survival according to the delay between histological diagnosis and surgical resection. On multivariate analysis adverse prognostic factors were advanced age, incomplete resection and lymph node involvement. Patients with a longer delay had a higher rate of complete tumour resection suggesting that they were more appropriately selected for the surgical treatment approach. In conclusion we have found no evidence that shorter delays from the date of histological diagnosis to surgical resection are beneficial to long-term survival.

摘要

这项回顾性研究调查了食管癌诊断与手术切除之间的延迟是否会影响长期生存率。对西米德兰兹癌症情报部门保存的1995年至2000年间因食管癌或食管胃交界部癌接受食管切除术的800例患者的数据进行了回顾。分析纳入了632例接受根治性治疗且未接受放疗或化疗形式的新辅助治疗的患者。组织学诊断与手术切除之间的时间间隔分为四组:少于3周、3 - 6周、6 - 9周和超过9周。采用Cox比例风险模型来检验延迟的独立影响。结果显示,根据组织学诊断与手术切除之间的延迟情况,长期生存率没有差异。多因素分析显示,不良预后因素为高龄、切除不完全和淋巴结受累。延迟时间较长的患者肿瘤完全切除率较高,这表明他们更适合选择手术治疗方法。总之,我们没有发现证据表明从组织学诊断日期到手术切除的较短延迟对长期生存有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/10864ff1a9e7/95-6603333f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/30c65f5f8fa3/95-6603333f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/7e7b6af2c389/95-6603333f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/10864ff1a9e7/95-6603333f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/30c65f5f8fa3/95-6603333f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/7e7b6af2c389/95-6603333f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5400/2360528/10864ff1a9e7/95-6603333f3.jpg

相似文献

1
Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data.可切除食管癌患者诊断与手术之间的延迟会影响生存吗?一项基于西米德兰兹郡癌症登记数据的研究。
Br J Cancer. 2006 Oct 9;95(7):835-40. doi: 10.1038/sj.bjc.6603333. Epub 2006 Sep 12.
2
Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma.食管鳞状细胞癌手术切除后影响长期生存的因素分析。
Acta Chir Belg. 1999 May-Jun;99(3):113-8.
3
Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.食管及食管胃交界腺癌的食管切除术结果
ANZ J Surg. 2005 Jul;75(7):513-9. doi: 10.1111/j.1445-2197.2005.03433.x.
4
[Long-term survival after curative resection for oesophageal and cardia cancer].[食管癌和贲门癌根治性切除术后的长期生存]
Ugeskr Laeger. 2010 May 24;172(21):1597-602.
5
[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].[胸段食管癌手术切除术后患者的生存分析]
Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5.
6
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.年龄和合并症对食管和胃癌患者手术切除率和生存率的影响。
Br J Surg. 2012 Dec;99(12):1693-700. doi: 10.1002/bjs.8952.
7
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.伴有非区域淋巴结转移的食管癌切除术后长期生存的预测因素。
Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.
8
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
9
Pathological determinants of survival in node-negative oesophageal cancer.淋巴结阴性食管癌生存的病理决定因素。
Br J Surg. 2004 Dec;91(12):1586-91. doi: 10.1002/bjs.4778.
10
Esophageal squamous cell carcinoma: the specific limited place of surgery defined by a prospective multivariate study of prognostic factors after surgical approach.食管鳞状细胞癌:手术入路后预后因素的前瞻性多变量研究确定的特定有限手术部位。
Eur J Surg Oncol. 1992 Dec;18(6):563-71.

引用本文的文献

1
Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.中国河北食管癌患者手术治疗延迟与生存结局的关联
Front Oncol. 2024 Oct 28;14:1463517. doi: 10.3389/fonc.2024.1463517. eCollection 2024.
2
Time to treatment of esophageal cancer in Ontario: A population-level cross-sectional study.安大略省食管癌的治疗时间:一项基于人群的横断面研究。
JTCVS Open. 2022 Aug 20;12:430-449. doi: 10.1016/j.xjon.2022.08.004. eCollection 2022 Dec.
3
Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.

本文引用的文献

1
A report card on outcomes for surgically treated gastrointestinal cancers: are we improving?手术治疗胃肠道癌症的疗效报告卡:我们是否在进步?
J Surg Res. 2004 Oct;121(2):214-21. doi: 10.1016/j.jss.2004.04.002.
2
Systemic treatment of oesophageal cancer.食管癌的全身治疗
Eur J Gastroenterol Hepatol. 2004 Mar;16(3):249-54. doi: 10.1097/00042737-200403000-00002.
3
Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study.胃食管癌手术的死亡率和发病率:ASCOT多中心前瞻性队列研究的初步结果。
对于 T3 期肾细胞癌,根治性肾切除术延迟超过 60 天时死亡率增加。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211043963. doi: 10.1177/15330338211043963.
4
Timeliness of cancer care in a regional Victorian health service: A comparison of high-volume (Lung) and low-volume (oesophagogastric) tumour streams.维多利亚州区域性卫生服务机构中癌症治疗的及时性:高容量(肺部)和低容量(食管胃)肿瘤患者的比较。
Cancer Rep (Hoboken). 2021 Feb;4(1):e1301. doi: 10.1002/cnr2.1301. Epub 2020 Oct 7.
5
Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer.术前等待时间对临床 II/III 期胃癌患者生存的影响。
Gastric Cancer. 2019 Jul;22(4):864-872. doi: 10.1007/s10120-018-00910-y. Epub 2018 Dec 10.
6
Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.食管癌患者从诊断到治疗的等待时间对生存无影响。
Ann Surg Oncol. 2016 Aug;23(8):2679-89. doi: 10.1245/s10434-016-5191-6. Epub 2016 Mar 24.
7
Wait times from diagnosis to treatment in cancer.癌症从诊断到治疗的等待时间。
J Gynecol Oncol. 2015 Oct;26(4):246-8. doi: 10.3802/jgo.2015.26.4.246. Epub 2015 Sep 23.
8
Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes?肝门部胆管癌患者手术治疗的延误:时间是否会影响结局?
HPB (Oxford). 2014 May;16(5):469-74. doi: 10.1111/hpb.12156. Epub 2013 Aug 26.
9
Delay in diagnostic workup and treatment of esophageal cancer.食管癌的诊断和治疗延误。
J Gastrointest Surg. 2010 Mar;14(3):476-83. doi: 10.1007/s11605-009-1109-y. Epub 2009 Dec 10.
10
Do diagnostic delays in cancer matter?癌症的诊断延迟有关系吗?
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S9-S12. doi: 10.1038/sj.bjc.6605384.
BMJ. 2003 Nov 22;327(7425):1192-7. doi: 10.1136/bmj.327.7425.1192.
4
Prognostic factors relating to esophageal cancer.与食管癌相关的预后因素。
Minerva Chir. 2002 Dec;57(6):789-94.
5
Treatment outcomes of resected esophageal cancer.食管癌切除术后的治疗结果。
Ann Surg. 2002 Sep;236(3):376-84; discussion 384-5. doi: 10.1097/00000658-200209000-00014.
6
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.食管癌手术切除联合或不联合术前化疗:一项随机对照试验
Lancet. 2002 May 18;359(9319):1727-33. doi: 10.1016/S0140-6736(02)08651-8.
7
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.在晚期食管胃癌中,比较丝裂霉素、顺铂和持续静脉输注氟尿嘧啶(PVI 5-FU)与表柔比星、顺铂和PVI 5-FU的前瞻性随机试验。
J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105.
8
Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia.食管癌和贲门癌切除术后的手术工作量及结局
Br J Surg. 2002 Mar;89(3):344-8. doi: 10.1046/j.0007-1323.2001.02015.x.
9
Best palliation in esophageal cancer: surgery, stenting, radiation, or what?
Dis Esophagus. 2001;14(2):120-3. doi: 10.1046/j.1442-2050.2001.00168.x.
10
Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.环周切缘受累:食管癌手术后生存的独立预测因素。
Gut. 2001 May;48(5):667-70. doi: 10.1136/gut.48.5.667.